Integrated genomics-based discovery of new druggable kinases as a therapeutic target and cancer biomarker for lung cancer.

被引：0
|
作者：
Daigo, Yataro
Takano, Atsushi
Nakamura, Yusuke
机构：
[1] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga, Japan
[2] Shiga Univ Med Sci, Can Ctr, Otsu, Shiga, Japan
[3] Univ Tokyo, Inst Med Sci, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e23144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23144
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Characterization of OASEP1 as a biomarker and therapeutic target for oral cancer.
    Takano, Atsushi
    Yoshitake, Yoshihiro
    Shinohara, Masanori
    Daido, Yataro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Biomarker discovery and preclinical validation using mouse models of lung cancer.
    Shaw, Alice T.
    Gillette, Michael A.
    Dowdle, James A.
    Chang, Betty
    Saenz-Vash, Veronica
    Clauser, Karl
    Jaffe, Jacob
    Carr, Steven A.
    Jacks, Tyler
    CANCER RESEARCH, 2006, 66 (08)
  • [33] RASEF is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer
    Oshita, Hideto
    Nishino, Ryohei
    Takano, Atsushi
    Fujitomo, Takashi
    Aragaki, Masato
    Kato, Tatsuya
    Akiyama, Hirohiko
    Tsuchiya, Eiju
    Kohno, Nobuoki
    Nakamura, Yusuke
    Daigo, Yataro
    MOLECULAR CANCER RESEARCH, 2013, 11 (08) : 937 - 951
  • [34] Chondrolectin Is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer
    Masuda, Ken
    Takano, Atsushi
    Oshita, Hideto
    Akiyama, Hirohiko
    Tsuchiya, Eiju
    Kohno, Nobuoki
    Nakamura, Yusuke
    Daigo, Yataro
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7712 - 7722
  • [35] circRNA: A New Biomarker and Therapeutic Target for Esophageal Cancer
    Shoda, Katsutoshi
    Kuwano, Yuki
    Ichikawa, Daisuke
    Masuda, Kiyoshi
    BIOMEDICINES, 2022, 10 (07)
  • [36] COMMD4 in Lung Cancer: Towards a New Therapeutic Target and Diagnostic Biomarker
    Suraweera, A.
    Adams, M.
    Jekimovs, C.
    Richard, D.
    O'Byrne, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S419 - S419
  • [37] Characterization of URST1 as a biomarker and therapeutic target for lung cancer and oral cancer
    Takano, Atsushi
    Yoshitake, Yoshihiro
    Shinohara, Masanori
    Miyagi, Yohei
    Daigo, Yataro
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach
    Zhao, Junfei
    Cheng, Feixiong
    Wang, Yuanyuan
    Arteaga, Carlos L.
    Zhao, Zhongming
    MOLECULAR & CELLULAR PROTEOMICS, 2016, 15 (02) : 642 - 656
  • [39] Integrated clinical genomics: new horizon for diagnostic and biomarker discoveries in cancer
    Roukos, Dimitrios H.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (01) : 1 - 4
  • [40] ErbB4 Ectodomain as a Biomarker and a Potential Therapeutic Target for Breast Cancer.
    Hollmen, M.
    Liu, P.
    Wildiers, H.
    Reinvall, I.
    Vandorpe, T.
    Smeets, A.
    Deraedt, K.
    Vahlberg, T.
    Joensuu, H.
    Leahy, D.
    Schoffski, P.
    Elenius, K.
    CANCER RESEARCH, 2011, 71
12345